Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical and Experimental Neuroimmunology is Scopus-indexed (Q2, CiteScore 2.4). It is covered by India's One Nation One Subscription scheme for reading access. Published by John Wiley and Sons Inc.
Checked against the index lists dated .
ISSN 1759-1961Verify ISSN ↗
Publisher: John Wiley and Sons Inc
Cost to publish: About US$2,710 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Microbiology (miscellaneous) | 22 / 43 | 50th | Q2 |
| Neuroscience (miscellaneous) | 48 / 74 | 35th | Q3 |
| Neurology (clinical) | 268 / 403 | 33rd | Q3 |
| Immunology | 186 / 243 | 23rd | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q2, CiteScore 2.4.
Clinical and Experimental Neuroimmunology is Q2 in Immunology and Microbiology (miscellaneous) (rank 22 of 43), Q3 in Neuroscience (miscellaneous) (rank 48 of 74) and Q3 in Neurology (clinical) (rank 268 of 403), by CiteScore 2025. It is ranked in 4 subject areas in all.
Clinical and Experimental Neuroimmunology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 2.4, quartile Q2, 50th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.353, quartile Q3, with an H-index of 25.
The publisher lists an article processing charge of about US$2,710 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Clinical and Experimental Neuroimmunology is published by John Wiley and Sons Inc. Its ISSN is 1759-1961.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Clinical and Experimental Neuroimmunology has an h-index of 28 and a 2-year mean of 0.67 citations per paper (OpenAlex). Its Scopus CiteScore is 2.4, quartile Q2. On 2-year citations it ranks #32 of 43 Scopus journals in Immunology and Microbiology (miscellaneous).
Clinical and Experimental Neuroimmunology published 63 papers in 2025; its busiest recent year was 2017 with 91. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 93 research articles (2024–2026), authors are most often from Japan (69.9%), United States (4.7%) and Türkiye (2.7%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.